CluePoints

Our integrated data review platform powers nearly 12,000 users, has de-risked over 2,000 studies, and detected 220,000+ potential issues and counting. How? We’ll show you. Get a personalized demo experience: https://hubs.ly/Q03ch-fr0 Or watch our on-demand demo videos now: https://hubs.ly/Q03chVgg0 #ClinicalTrials #RBQM #DataOversight #AIinClinicalResearch

That’s a Wrap on the CluePoints US Ignyte Meeting 2025! 🚀 What an incredible few days filled with insightful discussions, inspiring ideas, and meaningful connections! The CluePoints Ignyte Meeting brought together brilliant minds, fostering collaboration and innovation that will shape the future of our industry. A huge thank you to all the attendees for your energy, engagement, and thoughtful contributions. Your passion and expertise made this event truly special! From deep discussions to shared moments of learning, we’re grateful to be part of such a dynamic community. Until next time—let’s keep the momentum going! 💡✨

In our recent poll, 55% of voters identified “Sponsor/CRO/staff alignment” as the biggest hurdle in RBQM implementation. And we get it—successful RBQM hinges on buy-in, clear roles, and cross-functional collaboration. That’s why half of our RBQM Implementation Tip Sheet is dedicated to aligning your people. Doing this from the start accelerates adoption and maximizes impact. Download the full Tip Sheet here: https://hubs.ly/Q03chWK70 And get a deeper dive into team alignment, including: ✅ Define clear objectives: Align teams with measurable RBQM goals. ✅ Boost data literacy: Train teams to interpret and act on insights. ✅ Encourage collaboration: Engage cross-functional stakeholders early. ✅ Appoint an RBQM champion: Drive adoption and communication.

🏆 Congratulations to our 2025 CluePoints Champions! 🏆 At the 2025 CluePoints Annual Ignyte, we had the privilege of recognizing two outstanding individuals who embody the values that drive CluePoints forward. The CluePoints Champion Awards celebrate those who push boundaries, overcome challenges, and make a lasting impact in the industry. 🎉 Lynne Cesario – Executive Director, Global Risk-Based Monitoring Program Lead, Pfizer 🎉 Cris McDavid – Senior Director, Global Clinical Operations, Parexel These leaders exemplify innovation, strategic thinking, and advocacy, inspiring change in clinical trials and beyond. Thank you, Lynne and Cris, for your contributions to advancing risk-based quality management! Join us in celebrating their achievements! 👏 #CluePoints #Ignyte25 #ChampionAwards #RBQM #ClinicalTrials

Exciting news from Washington, DC! The 2025 CluePoints Annual Ignyte meeting is in full swing, and we’re thrilled to connect with our vibrant community and industry leaders. Get ready to explore our latest innovations, dive into ICH E6 R3 updates, and most importantly, hear from YOU—our valued clients and how they are leveraging CluePoints in clinical trials. Let’s make these next few days unforgettable! 💡

Letting the stats do the talking...

With the rise of ePROs, wearables, and telemedicine, DCTs are transforming how we collect and analyze data. But do you truly have full visibility across large-scale trials? 🕵️♀️ Join Laura Trotta, VP of Research, for an exclusive webinar on Wednesday, March 26th, at 10:00 AM ET. Laura will dive deep into risk detection and quality management, equipping you with the essential strategies to get ahead of DCT risks. Register today: https://hubs.ly/Q03804c60 #Decentralization #DCT #AuditTrailReview #RiskDetection

Not all sites need the same level of oversight. Some run smoothly, while others pose high-risk challenges—but with so much data, spotting the difference isn’t always easy. That’s where adaptive site monitoring comes in. Download our guide to learn how to identify high-risk sites early before issues escalate, move beyond rigid schedules, and optimize resources without sacrificing quality or compliance. Smarter site monitoring starts here. 📖 Grab your free copy now: https://hubs.ly/Q03chY100

💡 Big questions demand big conversations. Join CluePoints for a unique opportunity to network with top minds in clinical research, gain valuable insights, and get an in-depth look at our Product Roadmap. Arriving early? Kick things off at our Welcome Reception tonight. Register now: https://cvent.me/QVxB7R 📅 Wednesday & Thursday, March 19-20, 2025 ⏰ 9:00 AM ET 🌎 Westin Georgetown, Washington, D.C. 🍸 Welcome Reception: March 18, 7:00 – 9:00 PM ET #RBQM #ClinicalTrials #ClinicalResearch #DataScience

2024 was remarkable for CluePoints’ Central Monitoring Platform. ✅750 studies analyzed—35% growth vs. 2023 ✅351 first-time study analyses—47% growth vs. 2023 This momentum spans Risk Assessment, Data Quality Assessment, Key Risk Indicators, and Duplicate Patients. And we’re just getting started—stay tuned for updated FDA & EMA approval numbers. Better data means faster approvals. Be part of the next breakthrough: https://hubs.ly/Q03bPj8L0 #ClinicalTrials #ClinicalResearch #RBQM